ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
GreenWave
|
35 |
11K |
16 |
14:14 |
14:14 |
ASX - By Stock
|
35
|
11K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
GreenWave
|
35 |
11K |
19 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
35
|
11K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
GreenWave
|
35 |
11K |
17 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
35
|
11K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
GreenWave
|
51 |
23K |
23 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
23K
|
23
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
GreenWave
|
51 |
23K |
30 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
23K
|
30
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
GreenWave
|
743 |
329K |
18 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
743
|
329K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
GreenWave
|
743 |
329K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
743
|
329K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
GreenWave
|
743 |
329K |
16 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
743
|
329K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
GreenWave
|
743 |
329K |
9 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
743
|
329K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
GreenWave
|
743 |
329K |
9 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
743
|
329K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
GreenWave
|
2.6K |
1.0M |
8 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
GreenWave
|
2 |
1.7K |
0 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
2
|
1.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
GreenWave
|
2 |
1.7K |
12 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
2
|
1.7K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
An obsevation re Eftiligomab alfa
|
|
GreenWave
|
24 |
8.4K |
25 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
24
|
8.4K
|
25
|
|
ASX - By Stock
|
IMM |
Re:
Ann: PEI provides constructive feedback for ph3 lung cancer trial
|
|
GreenWave
|
8 |
6.0K |
17 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
8
|
6.0K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
The reason for the price increase ???
|
|
GreenWave
|
19 |
10K |
12 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
19
|
10K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Proposed issue of securities - IMM
|
|
GreenWave
|
2 |
1.3K |
17 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
2
|
1.3K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
GreenWave
|
2.6K |
1.0M |
14 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Completes Enrolment for TACTI-003 Phase IIb Trial
|
|
GreenWave
|
17 |
9.2K |
16 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
17
|
9.2K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Completes Enrolment for TACTI-003 Phase IIb Trial
|
|
GreenWave
|
17 |
9.2K |
4 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
17
|
9.2K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted US patent for IMP761 agonist LAG-3 antibody
|
|
GreenWave
|
21 |
8.8K |
5 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
21
|
8.8K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted US patent for IMP761 agonist LAG-3 antibody
|
|
GreenWave
|
21 |
8.8K |
6 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
21
|
8.8K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Publication of Abstracts for ASCO 2023 Annual Meeting
|
|
GreenWave
|
29 |
14K |
11 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
29
|
14K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
GreenWave
|
743 |
329K |
7 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
743
|
329K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
a current prediction
|
|
GreenWave
|
128 |
768K |
2 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
128
|
768K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
GreenWave
|
2.6K |
1.0M |
15 |
18/02/23 |
18/02/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
GreenWave
|
2.6K |
1.0M |
3 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
GreenWave
|
2.6K |
1.0M |
18 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board
|
|
GreenWave
|
35 |
11K |
14 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
35
|
11K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 4E & 2022 Full Year Statutory Accounts
|
|
GreenWave
|
12 |
4.2K |
7 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
12
|
4.2K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
GreenWave
|
41 |
22K |
11 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
41
|
22K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
GreenWave
|
2.6K |
1.0M |
10 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
10
|
|
ASX - By Stock
|
IMM |
Re:
The answer
|
|
GreenWave
|
20 |
10K |
3 |
11/06/22 |
11/06/22 |
ASX - By Stock
|
20
|
10K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep webcast for TACTI-002 data presented at ASCO 2022
|
|
GreenWave
|
10 |
5.8K |
0 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
10
|
5.8K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep webcast for TACTI-002 data presented at ASCO 2022
|
|
GreenWave
|
10 |
5.8K |
17 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
10
|
5.8K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ASCO 2022 abstracts
|
|
GreenWave
|
18 |
12K |
3 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
18
|
12K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ASCO 2022 abstracts
|
|
GreenWave
|
18 |
12K |
5 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
18
|
12K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
GreenWave
|
2.6K |
1.0M |
5 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
2.6K
|
1.0M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Half Yearly Report and Accounts
|
|
GreenWave
|
5 |
2.5K |
4 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
5
|
2.5K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Investor Update
|
|
GreenWave
|
13 |
5.8K |
6 |
20/02/22 |
20/02/22 |
ASX - By Stock
|
13
|
5.8K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Relatlimab versus Lag525
|
|
GreenWave
|
19 |
8.5K |
0 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
19
|
8.5K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
a current prediction
|
|
GreenWave
|
128 |
768K |
1 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
128
|
768K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
a current prediction
|
|
GreenWave
|
128 |
768K |
2 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
128
|
768K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
GreenWave
|
108 |
43K |
3 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
108
|
43K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
GreenWave
|
108 |
43K |
7 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
108
|
43K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
GreenWave
|
108 |
43K |
9 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
108
|
43K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
GreenWave
|
88 |
34K |
2 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
34K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
GreenWave
|
108 |
43K |
1 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
108
|
43K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
GreenWave
|
108 |
43K |
6 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
108
|
43K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
doin the hard yards...
|
|
GreenWave
|
26 |
11K |
12 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
26
|
11K
|
12
|
|